Skip to main content

Berlin is knorke: Biotechnology combined with Artificial Intelligence

Berlin, 27.1.2025

If you look deep enough into life using today’s methods, you very quickly end up in areas that the eye can no longer see and the imagination can only grasp with difficulty: the small-scale structure, i.e. the molecular composition, of proteins, fats or sugars. In order to analyse these and make them usable for applications, for example in medicine, biotechnology is indispensable. By combining them with Artificial Intelligence, these analyses become faster and solutions can be sought that otherwise could not be found or could only be found with great effort.

What has been summarised here in a few lines, however, is a complex process that only a few companies and researchers have mastered. One of these companies is Cambrium GmbH: a Berlin-based company that uses its expertise in biotechnology and Artificial Intelligence to develop sustainable, protein-based, alternatives for products that are currently either of animal or petroleum origin.

Their first product is NovaCollTM: a collagen that is already used in cosmetic products. This is not a product of animal origin, rather it is a collagen produced by biotechnological processes, which occurs identically in the human body.

So how does Cambrium manage to produce optimised human (i.e. “human-identical”) proteins without humans? For this purpose, the proteins are analysed at molecular level. We then look at the order in which the individual building blocks, the amino acids, occur and whether there is perhaps an optimised design. Bioinformatic methods are mainly used here. Once the correct amino acid sequence has been found, yeast cells are used: They produce the desired protein as part of a precision fermentation process. After purification, the product can be used.

The potential of this technology has already been fully recognised and rewarded accordingly: In 2024 alone, Cambrium won four prizes, including the Berlin Brandenburg Innovation Award 2024 and the Deep Tech Award 2024. Further awards are sure to follow and we can only hope that the name will become the programme: Analogue to the diversity of species that developed in the Cambrian geological era, possible application scenarios are set to expand. This means that more sustainable protein alternatives will be available in the near future.

  • CAMBRIUM Team © Kathleen Pracht

     

TeilenShare

WHO Pandemic Early Warning Centre:

27.01.2022
The World Health Organization (WHO) will open a Global Hub for Pandemic and Epidemic Intelligence in Berlin this year, creating shared access to critical multisectoral data to better identify future health threats.

Read more

Venture Leap

27.01.2022
During the Corona crisis, this young company from the Charlottenburg Innovation Center (CHIC) developed its Probatix software - now a successful SaaS product that is in use throughout Germany.

Read more

BERLIN SIMPLIFIES PROCESSES.

27.01.2022
5Micron is developing a contactless sensor system that anonymously records encounters, but also movement patterns, for example in entrance zones. This function is intended to contribute to relieving the burden of everyday processes.

Read more

BERLIN IS ONE OF THE WORLD'S TOP LOCATIONS

27.01.2022
In recent years, the capital region has established itself as the leading German location for the healthcare industry, especially in the field of life sciences.

Read more

MELTING POT BERLIN AS EUROPE'S START-UP HOTSPOT

27.01.2022
"It is clear that Berlin is a very special place and offers great opportunities for entrepreneurs and new companies," says Stefan Franzke in an interview with VentureCapital Magazin.

Read more

BERLIN IN THE MOBILITY RANKING

27.01.2022
"Berlin offers the most alternatives to owning a car" - this is the finding of the SPREEFREUNDE Mobility Ranking. The agency examined the modes of transport in Germany's 30 largest cities.

Read more